|
Guardant Health Note11/1 (Principal)
|
6.1 |
$216M |
|
268M |
0.81 |
|
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
4.1 |
$146M |
|
141M |
1.03 |
|
Novocure Note11/0 (Principal)
|
3.8 |
$133M |
|
141M |
0.95 |
|
Cg Oncology
(CGON)
|
3.4 |
$120M |
|
3.2M |
37.73 |
|
Nuvasive Note 0.375% 3/1 (Principal)
|
3.2 |
$112M |
|
114M |
0.98 |
|
Xenon Pharmaceuticals
(XENE)
|
3.0 |
$107M |
|
2.7M |
39.37 |
|
Neurocrine Biosciences
(NBIX)
|
3.0 |
$106M |
|
918k |
115.22 |
|
Neogenomics Note 0.250% 1/1 (Principal)
|
2.7 |
$97M |
|
116M |
0.83 |
|
Apogee Therapeutics
(APGE)
|
2.7 |
$97M |
|
1.6M |
58.74 |
|
Apellis Pharmaceuticals
(APLS)
|
2.6 |
$90M |
|
3.1M |
28.84 |
|
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
|
2.3 |
$83M |
|
93M |
0.89 |
|
Dexcom Note 0.375% 5/1 (Principal)
|
2.3 |
$82M |
|
93M |
0.89 |
|
Align Technology
(ALGN)
|
2.2 |
$79M |
|
312k |
254.32 |
|
Guardant Health
(GH)
|
2.2 |
$77M |
|
3.3M |
22.94 |
|
Insulet Corp Note 0.375% 9/0 (Principal)
|
2.2 |
$76M |
|
64M |
1.20 |
|
Legend Biotech Corp Sponsored Ads
(LEGN)
|
2.1 |
$75M |
|
1.5M |
48.73 |
|
Viking Therapeutics
(VKTX)
|
2.1 |
$73M |
|
1.2M |
63.31 |
|
Kiniksa Pharmaceuticals Intl Ord Shs Cl A
(KNSA)
|
2.1 |
$72M |
|
2.9M |
24.99 |
|
Penumbra
(PEN)
|
2.0 |
$70M |
|
361k |
194.31 |
|
Dexcom Note 0.250%11/1 (Principal)
|
2.0 |
$70M |
|
74M |
0.95 |
|
Maravai Lifesciences Hldgs I Com Cl A
(MRVI)
|
2.0 |
$69M |
|
8.4M |
8.31 |
|
Day One Biopharmaceuticals I
(DAWN)
|
1.9 |
$68M |
|
4.9M |
13.93 |
|
Spyre Therapeutics Com New
(SYRE)
|
1.8 |
$64M |
|
2.2M |
29.41 |
|
Repligen Corporation
(RGEN)
|
1.7 |
$59M |
|
397k |
148.82 |
|
Irhythm Technologies
(IRTC)
|
1.6 |
$58M |
|
783k |
74.24 |
|
Travere Therapeutics Note 2.500% 9/1 (Principal)
|
1.5 |
$54M |
|
56M |
0.96 |
|
Alphatec Hldgs Note 0.750% 8/0 (Principal)
|
1.5 |
$53M |
|
58M |
0.90 |
|
Argenx Se Sponsored Adr
(ARGX)
|
1.5 |
$52M |
|
97k |
542.08 |
|
Edgewise Therapeutics
(EWTX)
|
1.5 |
$52M |
|
2.0M |
26.69 |
|
Inspire Med Sys
(INSP)
|
1.4 |
$50M |
|
239k |
211.05 |
|
Sarepta Therapeutics
(SRPT)
|
1.3 |
$46M |
|
370k |
124.89 |
|
Bridgebio Pharma Note 2.250% 2/0 (Principal)
|
1.3 |
$45M |
|
54M |
0.84 |
|
Intuitive Surgical Com New
(ISRG)
|
1.3 |
$45M |
|
91k |
491.27 |
|
Avadel Pharmaceuticals Com Shs
(AVDL)
|
1.3 |
$44M |
|
3.4M |
13.12 |
|
Bicara Therapeutics
(BCAX)
|
1.2 |
$42M |
|
1.7M |
25.47 |
|
Keros Therapeutics
(KROS)
|
1.2 |
$41M |
|
707k |
58.07 |
|
Glaukos
(GKOS)
|
1.2 |
$41M |
|
312k |
130.28 |
|
Madrigal Pharmaceuticals
(MDGL)
|
1.1 |
$39M |
|
184k |
212.22 |
|
Vaxcyte
(PCVX)
|
1.0 |
$34M |
|
298k |
114.27 |
|
Replimune Group
(REPL)
|
1.0 |
$34M |
|
3.1M |
10.96 |
|
Arvinas Ord
(ARVN)
|
0.9 |
$32M |
|
1.3M |
24.63 |
|
Krystal Biotech
(KRYS)
|
0.9 |
$31M |
|
169k |
182.03 |
|
Orthopediatrics Corp.
(KIDS)
|
0.9 |
$30M |
|
1.1M |
27.11 |
|
Dex
(DXCM)
|
0.8 |
$30M |
|
441k |
67.04 |
|
Biontech Se Sponsored Ads
(BNTX)
|
0.8 |
$29M |
|
248k |
118.77 |
|
Paragon 28
(FNA)
|
0.8 |
$28M |
|
4.1M |
6.68 |
|
Relay Therapeutics
(RLAY)
|
0.7 |
$25M |
|
3.5M |
7.08 |
|
Alphatec Hldgs Com New
(ATEC)
|
0.6 |
$23M |
|
4.0M |
5.56 |
|
Harrow Health
(HROW)
|
0.6 |
$20M |
|
440k |
44.96 |
|
Cullinan Oncology
(CGEM)
|
0.6 |
$20M |
|
1.2M |
16.74 |
|
Amphastar Pharmaceuticals In Note 2.000% 3/1 (Principal)
|
0.6 |
$20M |
|
18M |
1.06 |
|
EXACT Sciences Corporation
(EXAS)
|
0.6 |
$20M |
|
286k |
68.12 |
|
Ocular Therapeutix
(OCUL)
|
0.6 |
$20M |
|
2.2M |
8.70 |
|
Immatics SHS
(IMTX)
|
0.5 |
$19M |
|
1.6M |
11.41 |
|
Ironwood Pharmaceuticals Com Cl A
(IRWD)
|
0.5 |
$18M |
|
4.4M |
4.12 |
|
Boston Scientific Corporation
(BSX)
|
0.4 |
$16M |
|
189k |
83.80 |
|
Dianthus Therapeutics
(DNTH)
|
0.4 |
$14M |
|
494k |
27.38 |
|
4d Molecular Therapeutics In
(FDMT)
|
0.4 |
$13M |
|
1.2M |
10.81 |
|
Celcuity
(CELC)
|
0.4 |
$13M |
|
884k |
14.91 |
|
Oruka Therapeutics
(ORKA)
|
0.4 |
$13M |
|
516k |
24.51 |
|
Haemonetics Corp Mass Note3/0 (Principal)
|
0.3 |
$11M |
|
12M |
0.93 |
|
Alector
(ALEC)
|
0.3 |
$10M |
|
2.2M |
4.66 |
|
Zura Bio Class A Ord Shs
(ZURA)
|
0.3 |
$10M |
|
2.5M |
4.06 |
|
Insulet Corporation
(PODD)
|
0.3 |
$9.9M |
|
43k |
232.75 |
|
Nevro
(NVRO)
|
0.3 |
$9.5M |
|
1.7M |
5.59 |
|
Castle Biosciences
(CSTL)
|
0.3 |
$9.5M |
|
332k |
28.52 |
|
Xencor
(XNCR)
|
0.3 |
$9.4M |
|
466k |
20.11 |
|
Jasper Therapeutics Com New
(JSPR)
|
0.3 |
$9.1M |
|
483k |
18.81 |
|
Bridgebio Pharma
(BBIO)
|
0.2 |
$7.6M |
|
298k |
25.46 |
|
Lexeo Therapeutics
(LXEO)
|
0.2 |
$6.6M |
|
729k |
9.04 |
|
Pulmonx Corp
(LUNG)
|
0.2 |
$6.2M |
|
753k |
8.29 |
|
The Beauty Health Company Com Cl A
(SKIN)
|
0.2 |
$5.8M |
|
4.0M |
1.44 |
|
Cutera Note 4.000% 6/0 (Principal)
|
0.1 |
$5.0M |
|
29M |
0.17 |
|
Cutera Note 2.250% 6/0 (Principal)
|
0.1 |
$4.0M |
|
25M |
0.16 |
|
Fulcrum Therapeutics
(FULC)
|
0.1 |
$3.8M |
|
1.1M |
3.57 |
|
Verve Therapeutics
(VERV)
|
0.1 |
$3.0M |
|
624k |
4.84 |
|
Iovance Biotherapeutics
(IOVA)
|
0.1 |
$2.0M |
|
218k |
9.39 |
|
Hillevax
|
0.1 |
$1.9M |
|
1.1M |
1.76 |
|
Lexicon Pharmaceuticals Com New
(LXRX)
|
0.0 |
$1.3M |
|
802k |
1.57 |
|
Dbv Technologies S A Sponsored Adr
|
0.0 |
$1.1M |
|
1.6M |
0.70 |
|
Elevation Oncology
(ELEV)
|
0.0 |
$284k |
|
474k |
0.60 |